Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Vincent

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nature Reviews. Drug Discovery|July 8, 2017
Opportunities and challenges in phenotypic drug discovery: an industry perspectiveJohn G Moffat, Fabien Vincent, Jonathan A Lee, et al.
Nature Reviews. Drug Discovery|May 31, 2022
Phenotypic drug discovery: recent successes, lessons learned and new directionsFabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2009
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitorsFabien Vincent, Margaret T Nguyen, Daniel E Emerling, et al.
Molecular Biology of the Cell|May 16, 2008
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's diseaseKai-Hui Sun, Yolanda de Pablo, Fabien Vincent, et al.
Lupus Science & Medicine|February 24, 2022
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysisMelissa Northcott, Sarah Jones, Rachel Koelmeyer, et al.
ACS Chemical Biology|May 13, 2014
ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK Kinase isoforms to cellular signalingAtli Thorarensen, Mary Ellen Banker, Andrew Fensome, et al.
Cell Chemical Biology|September 5, 2020
Hit Triage and Validation in Phenotypic Screening: Considerations and StrategiesFabien Vincent, Paula M Loria, Andrea D Weston, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Science Translational Medicine|June 26, 2015
Developing predictive assays: the phenotypic screening "rule of 3"Fabien Vincent, Paula Loria, Marko Pregel, et al.
Plos One|March 27, 2018
Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretionErica Dresselhaus, James M Duerr, Fabien Vincent, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nature Reviews. Drug Discovery|July 8, 2017
Opportunities and challenges in phenotypic drug discovery: an industry perspectiveJohn G Moffat, Fabien Vincent, Jonathan A Lee, et al.
Nature Reviews. Drug Discovery|May 31, 2022
Phenotypic drug discovery: recent successes, lessons learned and new directionsFabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2009
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitorsFabien Vincent, Margaret T Nguyen, Daniel E Emerling, et al.
Molecular Biology of the Cell|May 16, 2008
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's diseaseKai-Hui Sun, Yolanda de Pablo, Fabien Vincent, et al.
Lupus Science & Medicine|February 24, 2022
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysisMelissa Northcott, Sarah Jones, Rachel Koelmeyer, et al.
ACS Chemical Biology|May 13, 2014
ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK Kinase isoforms to cellular signalingAtli Thorarensen, Mary Ellen Banker, Andrew Fensome, et al.
Cell Chemical Biology|September 5, 2020
Hit Triage and Validation in Phenotypic Screening: Considerations and StrategiesFabien Vincent, Paula M Loria, Andrea D Weston, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Science Translational Medicine|June 26, 2015
Developing predictive assays: the phenotypic screening "rule of 3"Fabien Vincent, Paula Loria, Marko Pregel, et al.
Plos One|March 27, 2018
Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretionErica Dresselhaus, James M Duerr, Fabien Vincent, et al.
Pageof 5